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Abstract 
 
Background: Sickle cell disease (SCD) patients often seek care in the Emergency Department (ED) due to vaso-occlusive 
crisis (VOC), the most common complication of SCD. Currently, no diagnostic test can determine if a SCD patient is 
having an acute VOC. Methodology: Irrespective of the clinical diagnosis and type of sickle cell crises the confirmation 
of haemoglobin pattern in sickle cell disease patients and healthy subjects were done by sickling test, hemoglobin 
electrophoresis or high performance liquid chromatography. Results: Irrespective of age and sex, most common variety of 
vaso-occlusive crisis was bony crisis including hand foot syndrome. About 91.2% patients demonstrated CRP positivity 
during the early phase of vaso-occlusive crisis. Subsequently the CRP positivity rate declined in the mid phase (28%) and 
late phase (2.4%) of vaso-occlusive crisis reflecting response to therapy. There is a significant difference of CRP status 
between non vasoocclusive and vaso–occlusive crisis of sickle cell disease patients. About 96.3% patients of non vaso-
occlusive crisis became CRP negative during their whole course of their crisis. Conclusion: Analysis of large number of 
cases with sickle cell vaso-occlusive crisis with quantitative serial measurement of CRP level is needed for better 
evaluation of patients during prodromal phase for effective and better management of these patients.  
 
Keywords: Sickle cell disease, vaso-occlusive crisis, C-reactive protein, marker, sickling test, hemoglobin 
electrophoresis, high performance liquid chromatography.  
Introduction 
 
Sickle cell disease (SCD) is one of the most common 
monogenic disorders globally with an autosomal 
recessive inheritance. This disorder is haemolytic 
in nature; it is a genetic disorder in which two 
abnormal genes are inherited from both 
parents.  
___________________________ 
*Correspondence  
Dr Anindya Sasmal  
Assistant Professor, Department of Radiodiagnosis,  
ICARE Institute of Medical Sciences and Research, 
Banbishnupur, Purba Medinipur, Haldia, West Bengal 
721645, India 
E-Mail: dr.asasmal2009@gmail.com 
 
It was first reported by J. B. Herrick (1910) 
among the African Negroes. Sickle cell disease 
is one of the grand disease in terminology of 
Victorian pathology because of its wide spread 
and molecular defect in sickle cell hemoglobin 
as described by Ingram (1956) is substitution 
of valine for glutamic acid at 6
th
 position of   
chain of haemoglobin. Sickle haemoglobin is 
abnormal due to point mutation in gene coding 
for it. The normal codon GAG at position 6 of 
globin mRNA is replaced by GUG (Marrotta et 
al 1977)[1-3].  
Several studies have reported regarding 
increased prevalence of this disease among the 
people of Orissa, especially in western part. In 
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Orissa high prevalence is seen among people of 
Agharia (30.6%), Kulta (9.4%), Tanti (18.4%) 
and among many other tribal casts as per 
previous studies (Kar BC et al 1986; Kar BC 
1991). Crisis is different types like vaso -
occlusive crisis or painful crisis, hyper -
haemolytic crisis, aplastic crisis and 
sequestration crisis. The most important 
predisposing factors for various crises are 
infection, dehydration, acidosis, exhaustion, 
atmospheric temperature variability, emotional 
and psychological disturbance etc .[4-6]  
 
Patients with sickle cell disease have 
intermittent painful crisis caused by occlusion 
of microcirculation with sickled cells. Crisis 
varies considerably in severity ranging from 
mild episodes that respond at home to simple 
analgesics and oral rehydration to extensive 
tissue infarction requiring parental opiates and 
intravenous fluid in hospital.  
V.S.S. Medical College is situated in Western 
Orissa and cater to a population of 6 –  8 
millions of adjoining districts and also part of 
Chhatisgarh. Large number of patients of 
sickle cell haemoglobinopathy attends 
paediatric Outdoor and Indoor. Considering the 
magnitude of this disease in this area this study 
was undertaken with following aim and 
objectives to find out the value of measurement 
of acute phase reactants like C-reactive protein 
as an objective marker of tissue ischemia 
during steady state, as an early marker in the 
diagnosis of vaso-occlusive crisis in sickle cell 
disorder and on response to treatment.  
Materials & Methods 
This study was conducted in the Outdoor and 
Indoor patients of   paediatric department and 
sickle cell clinic of V.S.S. Medical College, 
Burla. Study subjects in the age group of 6 
month to 14 yrs were enrolled in the study. The 
study subjects were divided into 5 separate group 
as per case definition specified.  
Inclusion Criteria 
 Group I: It includes patients of 
electrophorectically or high performance 
liquid chromatographically proved cases of 
homozygous sickle cell disease (HbSS) 
and sickle   thal disease (Hb S-   thal) 
who were in the steady state. Steady state 
means – Crisis free period extending for at 
least 3 weeks since last clinical event and 
3 months or more since last blood 
transfusion before the start of new clinical 
events.  
 Group II: It includes patients of 
electrophorectically or high performance 
liquid chromatographically proved cases of 
homozygous sickle cell disease (HbSS) 
and sickle   thal disease (Hb S-   thal) 
presenting with vaso-occlusive crisis of 
any variety.  
 Group III: It includes patients of 
electrophorectically or high performance 
liquid chromatographically proved cases of 
homozygous sickle cell disease (HbSS) 
and sickle   thal disease (Hb S-   thal) 
presenting with any crisis other than vaso-
occlusive crisis. 
Exclusion Criteria  
Patients of acute rheumatic fever, collagen 
vascular disease, infective hepatitis, infective 
endocarditis, portal hypertension, recent typhoid 
vaccination and meningitis were excluded from 
the study group.  
Methodology   
 Irrespective of the clinical diagnosis and type of 
sickle cell crises the confirmation of 
haemoglobin pattern in sickle cell disease 
patients and healthy subjects were done by 
sickling test, hemoglobin electrophoresis or high 
performance liquid chromatography. After 
careful selection of cases a detailed history and 
thorough clinical examination was done. In each 
case the following investigations were done as 
required for the study.  
Hematological Investigations  
A.  Routine Hematological Investigations  
a. Sickling Test: The sickling phenomenon 
was demonstrated by following methods. A 
drop of capillary blood was obtained by 
finger prick and. taken over a clean glass 
slide. A cover slip was put over it and 
carefully sealed with Vaseline. This 
preparation was kept at room temperature 
for 24 hrs and then examined under 
microscope to detect presence of sickled 
erythrocyte.[7]  
b. Haemoglobin Estimation (Hb%), differential 
count and comment on peripheral smear, 
total leucocyte count (TLC), total rbc count 
(TRBC), packed cell volume (PCV), 
erythrocyte sedimentation rate (ESR), total 
platelet count (TPC) and reticulocyte count 
was estimated in all the cases.[7]  
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B.   Special hematological investigations: Were 
done as and when necessary 
a. Haemoglobin Electrophoresis 
The principle of Hb-electrophoresis at alkaline 
pH is based on the alteration of haemoglobin 
molecule which follows certain amino acid 
substitution. In practice the method requires a 
source current, a buffer system and a supporting 
medium. Haemoglobin electrophoresis on acid 
agar gel provides valuable confirmatory and 
additional evidence. It is done in a citrate buffer 
at pH 6.0 to 6.2. HbF migrates slightly towards 
cathode and HbS and HbC towards anode, 
whereas most other variants remain in position of 
HbA close to the origin. The use of both a lkaline 
and acid agar gel electrophoresis serves to 
identity HbS and HbC separately and indicates 
presence of less common variants[7-8]. 
b. Estimation of foetal haemoglobin (Batke 
method)
 
0.6 ml of prepared hemolysate was taken with 10 
ml of Drabkins solution and was allowed to stand 
for 10 minutes. This mixture is called Cyanmeth 
haemoglobin (HICN). 5.6 ml of HICN was taken 
and 0.4 ml of 1.2 N sodium hydroxide was added 
to it. It was allowed to mix well for 2 minutes. 
Then 4 ml of saturated ammonium sulphate 
solution was added to it and mixed well. The 
mixture was filtered. The filtrate was compared 
with standard using green filter calorimeter with 
light of wave length 540 . Standard: 1.4 ml of 
HICN was taken in a test tube and 1.6 ml of 
distilled water was added to it. Then 2ml of 
saturated ammonium sulphate solution was added 
and mixed well. 0.5ml of the mixture was taken 
in to 4.5 ml of Drabkins solution and was 
compared in the calorimeter in green filter with 
the test. Calculation: (Reading of test x 
5)/Reading of standard = % of HbF 
c. Semiquantitative Estimation of C-reactive 
protein  
Semiquantitative estimation of C-reactive protein 
estimation was done by diagnostic kit 
manufactured by Span Diagnostic Ltd. (Surat, 
India) by rapid latex slide technique.  
Principle: This test based on the immunologic 
reaction between CRP as an antigen and latex 
particles have been coated with monospecific 
anti-human CRP and sensitized to detect levels 
greater than 6 g/ml CRP. The latex slide test 
has the advantage of rapid performance in 
comparison to other tests for detection of CRP.  
Sample: 5-10 ml venous blood was collected into 
sterile tube/vial without anticoagulant. Sample 
was allowed to clot at room temperature for 
several hours. After complete formation of clot 
serum was separated and was stored at 2 -4C. 
Reagents / Accessories (Supplied in the Kit)  
Reagent 1: CRP Latex Reagent 
Reagent 2: Positive Control Serum  
Reagent 3: Negative Control Serum 
Use of Controls: Positive and Negative Controls 
are not always required when the reagents are in 
continuous use as the variety of specimens being 
tested will ensure both agglutinated and 
nonagglutinated patterns frequently. However, 
such controls are provided in the kit for 
performing an occasional check. It is, therefore, 
not necessary to run Positive and Negative 
Controls with every test[9-10]. 
Procedure  
Qualitative Slide Test  
All reagents as well as the sample were allowed 
to reach room temperature: 
Using the disposable plastic dropper, one drop of 
undiluted test serum was placed within the 
circled area on the special slide provided in the 
kit. One drop of Latex CRP Reagent (the vial 
was shaken gently immediately before use) was 
added to the one drop of undiluted test serum and 
was mixed well with a disposable applicator stick 
and was spread out to the edge of the test area. 
The slide was rocked gently to and fro for 2 
minutes and was examined for macroscopic 
agglutination under direct light source. Note: For 
positive and negative controls, the same 
procedure was followed as mentioned above by 
taking pre-diluted control serum from respective 
vials. Note: Controls were not diluted.  
Interpretation: Qualitative Slide Test:  
Observation              
Conclusion 
i) Coarse agglutination: Strongly positive 
ii) Finer agglutination: Weakly positive 
iii) Smooth suspension without  :        
Negativeany noticeable change        
d. Other tests done: Blood pH Estimation by 
using pH Meter, serum bilirubin, arterial blood 
gas analysis, blood culture and sensitivity, slide 
for malaria parasite, quantitative buffy coat 
(QBC) test for malaria parasite, immuno 
chromatographic test (ICT) for malaria parasite 
and routine urine & stool examination, X-ray 
chest, ultrasound of abdomen and Mantoux Test. 
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In Group I total 25 patients were followed up by 
regular check up and by doing semi quantitative 
estimation of C-reactive protein every four 
monthly in their steady state. Initially 37 patients 
were enrolled but due to appearance of crisis or 
irregular follow up only 25 could satisfy the 
inclusion criteria of minimum of 3 steady state 
CRP reports out of a maximum 6.  
In Group II total 50 patients were taken as study 
subjects and semi quantitative estimation of C-
reactive protein were done on early (day 1–3), 
middle (day 4–7) and late (day 7 onwards) phase 
of vaso-occlusive crisis. Initially 56 cases were 
enrolled in this group but we have to drop out 6 
cases due to appearance of both vaso-occlusive 
and non vaso-occlusive crisis.  
In Group III total 20 patients were selected and 
their C-reactive protein status were studied on 
early (day 1 - 3), middle (day 4 – 7) and late (day 
7 onwards) phase of crisis. Initially 28 patients 
were enrolled in this group but 8 cases were 
excluded due to presence of vaso-occlusive and 
non-vaso-occlusive crisis. 
 
Results 
Figure 1: Age and sex distribution among Group I study participants  
There were 15 (60%) male and 10 (40%) female patients enrolled in Group – 1. Largest number of cases 15(60%) 
were between 2 – 5 yrs of age. The male patients outnumbered the female patients with a ratio of 1.5: 1 [Fig. 1].  
Table 1: Steady state CRP positivity in Group – I patients (n=25) 
Age (yrs) Sex No of patients 
CRP status 
Positive  (>6mg/l) Negative (<6mg/l) 
0 – 1 
Male 02 0 02 
Female 01 0 01 
2 – 5 
Male 09 0 09 
Female 06 0 06 
6 -14 
Male 04 0 04 
Female 03 0 03 
Total 25 0 25 
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Table 1 shows that number of patients were being CRP positive or negative during their steady state throughout the 
study period. It shows that regardless of age and sex patients were in 100% CRP negative status during their steady 
state.   
Table 2: Type of vaso-occlusive crisis in Group – II patients [n=50] 
Type of presentations 
No of patients  % of Prevalence 
Male  Female  Total  
Hand foot syndrome 04 02 06 12 
Other bony crisis 12 08 20 40 
Abdominal crisis 05 04 09 18 
Hepatic crisis 03 03 06 12 
CNS crisis 01 01 02 04 
Splenic crisis 01 01 02 04 
Acute chest syndrome 02 03 05 10 
Total 28 22 50 100 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Age and sex distribution among Group 2 study participants  
 
There were 28 (56%) male and 22 (44%) Female 
patients enrolled in Group II. Largest number of 
patients 31 (62%) were between 2–5 year of age. The 
male patients outnumbered the female patients with a 
ratio of 1.27:1 [Table 2/ Fig. 2]. Bony crisis including 
hand foot syndrome was the commonest mode of 
presentation of vaso-occlusive crisis encountered in 26 
(52%) of cases. Next common modes of presentation 
were abdominal crisis (18%) and hepatic crisis (12%). 
Acute chest syndrome was not very uncommon (10%). 
CNS crisis and splenic crisis were rare. There were no 
case of ocular crisis, renal crisis and priapism reported 
during study period [Table 2].   
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Table 3: CRP status in early phase of different types of vaso-occlusive crisis in Group – II patients [n=34] 
Type of crisis 
No.  
of patients 
CRP status 
Positive (> 6 mg/l) Negative (< 6 mg/l) 
M  F  T  % M  F  T % 
Hand foot syndrome 04 03 01 04 100 00 00 00 00 
Other bony crisis 15 07 07 14 93.3 01 00 01 6.7 
Abdominal crisis 06 01 03 04 66.7 01 01 02 33.3 
Hepatic crisis 04 03 01 04 100 00 00 00 00 
CNS crisis 01 01 00 01 100 00 00 00 00 
Splenic crisis 01 00 01 01 100 00 00 00 00 
Acute chest syndrome 03 01 02 03 100 00 00 00 00 
Total 34 16 15 31 91.2 02 01 03 8.8 
Though we enrolled total 50 patients in this group but in early phase only 34 cases were reported at the hospital. 
Irrespective of age and sex distribution maximum number of patients who presented in the early phase of vaso-
occlusive crisis was CRP positive. Total no. of CRP positive cases in this phase was 31 (91.2%) and CRP negative 
cases were 3 (8.8%) [Table 3]. 
Table 4: CRP status in middle phase of different type of vaso-occlusive crisis in Group – II patients 
Type of crisis 
No. of 
pt. 
CRP Status 
Positive (> 6 mg/l) Negative (> 6 mg/l) 
M  F T  % M  F  T  % 
Hand foot syndrome 06 01 00 01 16.7 03 02 05 83.3 
Other bony crisis  20 02 01 03 15 10 07 17 85 
Abdominal crisis  09 01 01 02 22.2 04 03 07 77.8 
Hepatic crisis  06 01 01 02 33.5 03 01 04 66.5 
CNS crisis 02 01 01 02 100 00 00 00 00 
Splenic crisis  02 00 00 00 00 01 01 02 100 
Acute chest syndrome  05 01 03 04 80 01 00 01 20 
Total  50 07 07 14 28 22 14 36 72 
Irrespective of age and sex distribution CRP positivity rate was low in the middle phase. Total no of CRP positive 
cases in this phase were 14 (28%) and CRP negative cases were 36 (72%) [Table 4].   
Table 5: CRP status in late phase of different type of vaso-occlusive crisis in Group – II patients [n=41] 
Type of crisis 
No. of 
pt. 
CRP Status 
Positive  (> 6mg/l) Negative  (< 6mg/l) 
M  F  T % M F T % 
Hand foot syndrome 02 00 00 00 00 02 00 02 100 
Other bony crisis  16 00 00 00 00 10 06 16 100 
Abdominal crisis  09 00 00 00 00 05 04 09 100 
Hepatic crisis  06 00 01 01 16.7 03 02 05 83.3 
CNS crisis 02 00 00 00 00 01 01 02 100 
Splenic crisis  02 00 00 00 00 01 01 02 100 
Acute chest syndrome  04 00 00 00 00 01 03 04 100 
Total  41 00 01 01 2.4 23 17 40 97.6% 
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CRP status among the total 41 patients during late 
phase (day 7 onwards) of vaso-occlusive crisis was 
estimated. Though we enrolled total 50 patients, in this 
group only 41 cases were available during late phase of 
crisis because of nine drop outs which includes 2 
deaths, 4 lost to follow up and 3 patients left the 
hospital without any information. 
 Maximum number of patients irrespective of their age 
and sex became CRP negative during late phase of 
crisis or remission phase of crisis. In this phase total no 
of CRP positive case was only 1 (2.4%) and total no of 
CRP negative cases were 40 (97.6%) [Table 5]. There 
were 9 (45%) male and 11 (55%) female patients 
enrolled in Group III. Largest number of patients 10 
(50%) were between 6-14 yrs of age followed by 8 
(40%) were between 2-5 yrs of age. The female 
patients outnumbered the male patients with a ratio of 
1.2: 1. This showed that non vaso-occlusive crisis was 
equally prevalent in either sex between 2–5 yrs and 6–
14 yrs of age group [Fig. 3]. 
 
Figure 3: Age and sex distribution among Group III study participants 
Table 6: Type of non vaso-occlusive crisis in Group III patients [n=20] 
Type of crisis 
No of patients  
Total Percentage  
Male  Female  
Aplastic crisis  02 01 03 15 
Hyper haemolytic crisis  05 10 15 75 
Sequestration crisis  02 00 02 10 
Total  09 11 20 100 
Regardless of age and sex hyper haemolytic crisis (75%) was being most common type of non – vaso-occlusive 
crisis followed by aplastic (15%) and sequestration (10%) crisis [Table 6].  
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Table 7: CRP status in early phase of non vaso-occlusive crisis in group III patients (n=13) 
Type of crisis 
No. of pt. 
CRP Status  
Positive   
(> 6mg/l) 
Negative  
(< 6mg/l) 
M  F T %  M F  T  % 
Aplastic crisis  02 00 00 00 00 02 00 02 100 
Hyper haemolytic crisis  09 00 00 00 00 04 05 09 100 
Sequestration crisis  02 00 00 00 00 02 00 02 100 
Total  13 00 00 00 00 08 05 13 100 
CRP status in the early phase of non vaso–occlusive crisis among 13 Group III cases was analyzed. Though total 20 
cases were enrolled in group III, only 13 cases were reported during early phase of non vaso-occlusive crisis. It 
showed that 100% patients were CRP negative during early phase of non vaso-occlusive crisis irrespective of their 
age & sex [Table 7].  
Table 8: CRP status in middle phase of non vaso-occlusive crisis in Group III patients [n=18] 
Type of crisis No. of pt. 
CRP Status 
Positive (> 6mg/l) Negative (< 6mg/l) 
M  F T %  M  F T %  
Aplastic crisis  03 00 00 00 00 01 02 03 100 
Hyper haemolytic crisis  15 01 01 02 13.3 04 09 13 86.7 
Sequestration crisis  00 00 00 00 00 00 00 00 00 
Total  18 01 01 02 11.1 05 11 16 88.9 
 CRP status in middle phase of non vaso – occlusive crisis among 18 Group III patients was analyzed. Though total 
20 cases were enrolled in this group, 2 cases of sequestration crisis who presented during early phase, died after 2 
days of hospital admission.  It showed that only 2 (11.1%) cases became CRP positive during middle phase of crisis 
but 16 (88.9%) cases still remained CRP negative [Table 8].  
Table 9: CRP status in late phase of non vaso-occlusive crisis in Group III patients [n=16] 
Type of crisis 
No. of 
pt. 
CRP Status 
Positive (> 6mg/l) Negative (< 6mg/l) 
M  F T %  M  F T %  
Aplastic crisis  01 00 00 00 00 01 00 01 100 
Hyper haemolytic crisis  15 00 00 00 00 05 10 15 100 
Sequestration crisis  00 00 00 00 00 00 00 00 100 
Total  16 00 00 00 00 06 10 16 100 
Among the 20 patients enrolled, 2 cases of 
sequestration crisis and 2 cases of aplastic crisis died 
during the hospitalization. It appeared that 100% 
patients became CRP negative in the late phase of 
crisis [Table 9]. Another comparison is done between 
the two groups of patients i.e. Group II (During vaso-
occlusive crisis of sickle cell SS and S thal disease 
patients) and Group III (During non vaso-occlusive 
crisis of sickle cell SS and S thal disease patients). 
CRP status in both these groups were studied in three 
phases early (day 1 –3), middle (day 4 – 7) and late 
(day 7 onwards). It was found that in group II 91.2% 
patients in early phase, 28% patients in middle phase 
and 2.4% patients in late phase became CRP positive. 
So in the case of vaso-occlusive crisis it was noted that 
maximum percentage of patients become CRP positive 
at the onset of crisis. Gradually they had became CRP 
negative in middle and late i.e. remission phase of 
crisis.  
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 It was found that in Group III 100% patients in early 
phase, 88.9% patients in middle phase and 100% 
patients in the late phase became CRP negative. So in 
the case of non vaso-occlusive crisis maximum 
percentage of patients became CRP negative 
throughout the course of their non vaso-occlusive 
crisis.  
So by comparing these two groups and by doing 
statistical analysis it was observed that CRP status is a 
good marker to know the onset of vaso-occlusive crisis 
and subsequently CRP status (negativity ) is a good 
marker to know the resolution of vaso-occlusive crisis 
and the response to treatment but CRP negativity 
cannot exclude the occurrence of other crises. So by 
applying following method, we found out the utility of 
CRP level estimation during the prodromal phase of 
vaso-occlusive crisis.  
 
Table 10: Screening test 
Screening test 
(CRP status) 
Vaso-occlusive crisis Total 
Yes No 
+ve 21 17 04 21 
-ve 29 04 25 29 
 
Sensitivity = %7.85100
21
17
417
17


x  
Specificity = %2.86100
29
25
425
25


x  
Positive predictive value = %7.85100
21
17
x  
Negative predictive value = %2.86100
29
25
x  
% of false negative = %05.19100
21
4
x  
% of false positive = %7.13100
29
4
x  
 
Discussion 
 
Present study showed that number of patients was 
being CRP positive or negative during their steady 
state throughout the study period. It shows that 
regardless of age and sex patients were in 100% CRP 
negative status during their steady state. A. Singhal and 
GR Serjeant (1993) by their study reported that 
percentage of CRP positivity among sickle cell patient 
is 18% during their steady state who were symptomless 
for preceding 2 weeks. The present study enrolled 
sickle cell patients who were symptomless for 
preceding three weeks and did not receive blood 
transfusion for preceding 3 months. This probably 
accounts for very high level of steady state CRP 
negativity here[11].   
 
In the present study bony crisis including hand foot 
syndrome was the commonest mode of presentation of 
vaso-occlusive crisis encountered in 26 (52%) of cases. 
Next common modes of presentation were abdominal 
crisis (18%) and hepatic crisis (12%). Acute chest 
syndrome was not very uncommon (10%). CNS crisis 
and splenic crisis were rare. There were no case of 
ocular crisis, renal crisis and priapism reported during 
study period.  
Konetey–Ahulu (1974), Serjeant (1970) observed 
polyarthralgia as a presenting feature of bony crisis in 
sickle cell vaso-occlusive crisis[12-13]. Incidence of 
bony crisis as reported by Konoteny - Ahulu (1974) is 
89.4%[12]. Serjeant (1985) also reported that 
prevalence of bony crisis is very high among Indian 
sickle cell patients during his study with incidence of 
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hand foot syndrome being 20%.  The present study 
demonstrated prevalence of bony crisis as 40% and 
hand foot syndrome as 12%[14]. 
Abdominal crisis and splenic crisis presenting as acute 
abdominal pain had been observed by Handerson 
(1950) and Diggs (1965) during the vaso-occlusive 
crisis in sickle cell patient. Similarly Praharaj (1969)
 
have reported 25% of abdominal crisis in his study 
series. Nanda BK et al (1967) reported, 20% of splenic 
crisis presenting as abdominal pain during his study. 
Prevalence of abdominal and splenic crisis was 18% 
and 12% respectively in the present study[15-18]. 
Eva Svarch et al (2001)[19] studied the incidence of 
acute chest syndrome in sickle cell patients of Cuba 
and reported a prevalence of 22%. In current study 
prevalence was 10%. Though ocular crisis, renal crisis 
and priapism is not very rare in African sickle cell 
children as told by Talbot JF (1988)[20] these three 
varieties of crises are rare in Indian sickle cell children 
(Kar BC et al 1986)[4]. Not a single case of ocular 
crisis, renal crisis or priapism was detected during the 
ongoing study.  
Maximum number of patients irrespective of their age 
and sex became CRP negative during late phase of 
crisis or remission phase of crisis. In this phase total no 
of CRP positive case was only 1 (2.4%) and total no of 
CRP negative cases were 40 (97.6%). Akinola (1992) 
studied CRP level among 20 patients of sickle cell 
anaemia with vaso – occlusive crisis. He found that out 
of 20 patients, 15 patients were CRP positive (75%) on 
day 1 of crisis and became CRP negative after 7 day of 
onset of crisis[21]. 
 J. Stuart, P.C.W Stone (1994) studied measurement of 
CRP level among 14 established cases of vaso–
occlusive crisis. They reported in their study that C-
reactive protein increases early in the crisis in near 
about 98% of cases. But in majority (78%) cases whose 
crises subsided within 3 days showed a fall of C-
reactive protein after 2–3 days of onset of crisis. They 
found in 2 (14%) cases whose crisis persisting for more 
than 7 days became CRP positive till day 8 of 
crisis[22].  
 Eva Svarch et al (2001) after their study regarding the 
elevation of CRP during vaso – occlusive crisis of 
sickle cell disease children in Cuba reported that 
among 83 patients, they found increased C – reactive 
protein in 100% of them during early phase of crisis 
but CRP positivity in 15% of them during late phase of 
crisis. Among the 20 patients enrolled, 2 cases of 
sequestration crisis and 2 cases of aplastic crisis died 
during the hospitalization. It appeared that 100% 
patients became CRP negative in the late phase of 
crisis[19].  
Akinola NO, Stevens SM (1992) also described similar 
type of prodormal phase in vaso-occlusive crisis. They 
reported in their study that in 60% of sickle cell 
patients’ CRP level was increased during prodormal 
phase as compared to their CRP level in Steady state 
and these percentage of patients ultimately developed 
vaso-occlusive crisis 6-7 days after the rise of CRP 
level and subsequently as crisis evolved, these patients’ 
CRP level became decreased to normal steady state 
CRP level[21]. 
JF Dohery, A Singhal and GR Serjeant (1993)[11] also 
by their studies reported that during monitoring of 
steady state C-Reactive patients in sickle cell patients 
54% developed increased levels of CRP. They 
followed up these patients and saw that ultimately 
these patients developed vaso-occlusive crisis during 
follow up. They also described this phase of steady 
state as prodromal phase of vaso–occlusive crisis.  
P Hernandez, Eva Svarch (2001)[19] studied 83 
patients with sickle cell anaemia and they found 
increased C-reactive protein in 55% of them during the 
steady state and they found during the follow up of 
these patients that these 55% patients developed vaso-
occlusive crisis within 4-5 days of CRP positivity.  
Conclusion  
The most common crisis in sickle cell disease is vaso-
occlusive crisis which may have various modes of 
presentation starting from hand foot syndrome to 
ocular crisis. If early intervention is not done during 
tissue ischemia or infraction due to vaso-occlusive 
crisis, it will increase the morbidity in sickle cell 
disease patients by persisting sequelae of different 
organ damage.  If vaso-occlusive crisis can be 
diagnosed as early as in prodromal phase, extent of 
tissue ischemia can be minimized by early institution 
of therapy. There is no significant difference between 
steady state CRP status in sickle cell disease patients 
and healthy AA patients. CRP status as an early marker 
during prodromal phase of vaso-occlusive crisis was 
found out to be having 85.7% sensitivity, 86.2% 
specificity, 85.7% positive predictive value, 86.2% 
negative predictive value with percentage of false 
negativity 19.05% and percentage of false positivity 
13.7%. Analysis of large number of cases with sickle 
cell vaso-occlusive crisis with quantitative serial 
measurement of CRP level is needed for better 
evaluation of patients during prodromal phase for 
effective and better management of these patients.  
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